Last update 16 May 2025

Hemay-102

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HEMAY 102, HEMAY102
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmLocally Advanced Hepatocellular Carcinoma
Originator Organization
Tianjin Hemei Biological Technology Co.,Ltd.
Active Organization-
Inactive Organization
Tianjin Hemei Biological Technology Co.,Ltd.Hainan Hailing Chemipharma Corp. Ltd.Hainan Hailing Chemipharma Corp. Ltd.Xiajiang Hemei Pharmaceutical Co., Ltd.
+ [1]
License Organization-
Drug Highest PhaseSuspendedPhase 1
First Approval Date-
RegulationSpecial Review Project (China)
Login to view timeline

Related

2
Clinical Trials associated with Hemay-102
NCT03982303
/ Unknown statusPhase 1
A Dose Escalation Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Hemay102 in Patients With Advanced Solid Tumors
CTR20181497
/ SuspendedPhase 1
评价Hemay102在晚期实体瘤患者中安全性、耐受性、药代动力学特征和初步抗肿瘤疗效的剂量递增Ⅰ期临床研究
[Translation] A phase I dose-escalation clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary anti-tumor efficacy of Hemay102 in patients with advanced solid tumors
100 Clinical Results associated with Hemay-102
Login to view more data
100 Translational Medicine associated with Hemay-102
Login to view more data
100 Patents (Medical) associated with Hemay-102
Login to view more data
100 Deals associated with Hemay-102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Tianjin Hemei Aokang Pharmaceutical Technology Co., Ltd.
03 Jan 2019
Locally Advanced Hepatocellular CarcinomaPhase 1
China
Hainan Hailing Chemipharma Corp. Ltd.Hainan Hailing Chemipharma Corp. Ltd.
24 Dec 2018
Locally Advanced Hepatocellular CarcinomaPhase 1
China
Xiajiang Hemei Pharmaceutical Co., Ltd.
24 Dec 2018
Locally Advanced Hepatocellular CarcinomaPhase 1
China
Tianjin Hemei Biological Technology Co.,Ltd.
24 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free